119
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Relationship of Single Nucleotide Polymorphisms and Haplotype Interaction of Mitochondrial Unfolded Protein Response Pathway Genes with Head and Neck Cancer

, , , , &
Pages 3819-3829 | Received 26 Jun 2019, Accepted 04 Sep 2019, Published online: 25 Oct 2019

References

  • Sena LA , LiS, JairamanAet al. Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling. Immunity38(2), 225–236 (2013).
  • Lee S-J , HwangAB, KenyonC. Inhibition of respiration extendsC. elegans life span via reactive oxygen species that increase HIF-1 activity. Curr. Biol.20(23), 2131–2136 (2010).
  • Yang W , HekimiS. A mitochondrial superoxide signal triggers increased longevity inCaenorhabditis elegans. PLoS Biol.8(12), e1000556 (2010).
  • Diebold L , ChandelNS. Mitochondrial ROS regulation of proliferating cells. Free Radic. Biol. Med.100, 86–93 (2016).
  • Kenny TC , GermainD. mtDNA, metastasis, and the mitochondrial unfolded protein response (UPRmt). Front. Cell. Dev. Biol.5, 37 (2017).
  • Münch C . The different axes of the mammalian mitochondrial unfolded protein response. BMC Biol.16(1), 81 (2018).
  • Papa L , GermainD. Estrogen receptor mediates a distinct mitochondrial unfolded protein response. J. Cell Sci.124(9), 1396–1402 (2011).
  • Radke S , ChanderH, SchäferPet al. Mitochondrial protein quality control by the proteasome involves ubiquitination and the protease Omi. J. Biol. Chem.283(19), 12681–12685 (2008).
  • Papa L , GermainD. SirT3 regulates the mitochondrial unfolded protein response. Mol. Cell. Biol.34(4), 699–710 (2014).
  • Torrens-Mas M , OliverJ, RocaP, Sastre-SerraJ. SIRT3: oncogene and tumor suppressor in cancer. Cancers9(7), 90 (2017).
  • Hirschey M , ShimazuT, HuangJ-Y, SchwerB, VerdinE. SIRT3 regulates mitochondrial protein acetylation and intermediary metabolism. Cold Spring Harbor Symp. Quant. Biol.76, 267–77 (2011).
  • Anderson KA , HirscheyMD. Mitochondrial protein acetylation regulates metabolism. Essays Biochem.52, 23–35 (2012).
  • Paik J-H , KolliparaR, ChuGet al. FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis. Cell128(2), 309–323 (2007).
  • Ward EC , HoekstraAV, BlokLJet al. The regulation and function of the forkhead transcription factor, Forkhead box O1, is dependent on the progesterone receptor in endometrial carcinoma. Endocrinology149(4), 1942–1950 (2007).
  • Yi L , ShenH, ZhaoMet al. Inflammation-mediated SOD-2 upregulation contributes to epithelial-mesenchymal transition and migration of tumor cells in aflatoxin G 1-induced lung adenocarcinoma. Sci. Rep.7(1), 7953 (2017).
  • Kim Y , GuptaVallur P, PhaetonR, MythreyeK, HempelN. Insights into the dichotomous regulation of SOD2 in cancer. Antioxidants6(4), 86 (2017).
  • Mahjabeen I , BaigRM, MasoodNet al. Genetic variations in XRCC1 gene in sporadic head and neck cancer (HNC) patients. Pathol. Oncol. Res.19(2), 183–188 (2013).
  • Ye S , DhillonS, KeX, CollinsAR, DayIN. An efficient procedure for genotyping single nucleotide polymorphisms. Nucleic Acids Res.29(17), e88 (2001).
  • Mahjabeen I , BaigRM, MasoodN, SabirM, MalikFA, KayaniMA. OGG1 gene sequence variation in head and neck cancer patients in Pakistan. Asian Pac. J. Cancer Prev.12(10), 2779–2783 (2011).
  • Bhurgri Y , BhurgriA, NishterSet al. Pakistan-country profile of cancer and cancer control 1995–2004. J. Pak. Med. Assoc.56(3), 124 (2006).
  • Mahjabeen I , KayaniMA. Loss of mitochondrial tumor suppressor genes expression is associated with unfavorable clinical outcome in head and neck squamous cell carcinoma: data from retrospective study. PLoS ONE11(1), e0146948 (2016).
  • Chen Y , ZhangJ, LinYet al. Tumour suppressor SIRT3 deacetylates and activates manganese superoxide dismutase to scavenge ROS. EMBO Rep.12(6), 534–541 (2011).
  • Kim H-S , PatelK, Muldoon-JacobsKet al. SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell17(1), 41–52 (2010).
  • Jacobs KM , PenningtonJD, BishtKSet al. SIRT3 interacts with the daf-16 homolog FOXO3a in the mitochondria, as well as increases FOXO3a dependent gene expression. Int. J. Biol. Sci.4(5), 291 (2008).
  • Kenny T , HartP, RagazziMet al. Selected mitochondrial DNA landscapes activate the SIRT3 axis of the UPR mt to promote metastasis. Oncogene36(31), 4393 (2017).
  • Saeed S , MahjabeenI, SarwarR, BashirK, KayaniMA. Haplotype analysis of XRCC2 gene polymorphisms and association with increased risk of head and neck cancer. Sci. Rep.7(1), 13210 (2017).
  • Masood N , KayaniMA. Mutational analysis of xenobiotic metabolizing genes (CYP1A1 and GSTP1) in sporadic head and neck cancer patients. Genet. Mol. Biol.34(4), 533–538 (2011).
  • Rudijono A , SuhartonoA, MidoenY, TalbotC, AuerkariE. Association between IL-1RN VNTR polymorphism and head and neck cancer in Indonesian population. J. Phys.1073, 032063 (2018).
  • Makni L , HamdaCB, AlAnsari Aet al. Association of common IL-10 promoter gene variants with the susceptibility to head and neck cancer in Tunisia. Turk. J. Med. Sci.49(1), 123–128 (2019).
  • Sabir M , BaigRM, MahjabeenI, KayaniMA. Significance of cyclin D1 polymorphisms in patients with head and neck cancer. Int. J. Biol. Markers28(1), 49–55 (2013).
  • Deng N , ZhouH, FanH, YuanY. Single nucleotide polymorphisms and cancer susceptibility. Oncotarget8(66), 110635 (2017).
  • Zhang X , BaileySD, LupienM. Laying a solid foundation for Manhattan–‘setting the functional basis for the post-GWAS era’. Trends Genet.30(4), 140–149 (2014).
  • Aouacheria A , NavratilV, López-PérezRet al. In silico whole-genome screening for cancer-related single-nucleotide polymorphisms located in human mRNA untranslated regions. BMC Genomics8(1), 2 (2007).
  • Gresner P , GromadzinskaJ, TwardowskaE, RydzynskiK, WasowiczW. Rad51C: a novel suppressor gene modulates the risk of head and neck cancer. Mutat. Res.762, 47–54 (2014).
  • Bhowmik A , DasS, BhattacharjeeAet al. MDM2 and TP53 polymorphisms as predictive markers for head and neck cancer in Northeast Indian population: effect of gene–gene and gene–environment interactions. Asian Pac. J. Cancer Prev.16(14), 5767–5772 (2015).
  • Almal SH , PadhH. Variation in copy number of MTUS1 gene among healthy individuals and cancer patients from Gujarat. Indian J. Pharm. Sci.79(2), 311–316 (2017).
  • Tan C , LiuS, TanSet al. Polymorphisms in microRNA target sites of forkhead box O genes are associated with hepatocellular carcinoma. PLoS ONE10(3), e0119210 (2015).
  • Haneklaus M , GerlicM, O’NeillLA, MastersS. miR-223: infection, inflammation and cancer. J. Intern. Med.274(3), 215–226 (2013).
  • Shi R , ZhouX, JiW-Jet al. The emerging role of miR-223 in platelet reactivity: implications in antiplatelet therapy. Biomed. Res. Int.2015, 981841 (2015).
  • Bain C , ScottC, Uronen-HanssonHet al. Resident and pro-inflammatory macrophages in the colon represent alternative context-dependent fates of the same Ly6C hi monocyte precursors. Mucosal Immunol.6(3), 498 (2013).
  • Lee JC , EspéliM, AndersonCAet al. Human SNP links differential outcomes in inflammatory and infectious disease to a FOXO3-regulated pathway. Cell155(1), 57–69 (2013).
  • Bag A , BagN. Target sequence polymorphism of human manganese superoxide dismutase gene and its association with cancer risk: a review. Cancer Epidemiol. Biomarkers Prev.17(12), 3298–3305 (2008).
  • Gazouli M . Re: clinical significance of SOD2 and GSTP1 gene polymorphisms in Chinese patients with gastric cancer by Xu et al. Transl. Gastrointest. Cancer118(22), 5489–5496 (2013).
  • Nahon P , SuttonA, RufatPet al. Myeloperoxidase and superoxide dismutase 2 polymorphisms comodulate the risk of hepatocellular carcinoma and death in alcoholic cirrhosis. Hepatology50(5), 1484–1493 (2009).
  • Yi J-F , LiY-M, LiuTet al. Mn-SOD and CuZn-SOD polymorphisms and interactions with risk factors in gastric cancer. World J. Gastroenterol.16(37), 4738 (2010).
  • Xu Z , ZhuH, LukJMet al. Clinical significance of SOD2 and GSTP1 gene polymorphisms in Chinese patients with gastric cancer. Cancer118(22), 5489–5496 (2012).
  • Leoncini E , VukovicV, CadoniGet al. Clinical features and prognostic factors in patients with head and neck cancer: results from a multicentric study. Cancer Epidemiol.39(3), 367–374 (2015).
  • Azad AK , BairatiI, SamsonEet al. Validation of genetic sequence variants as prognostic factors in early-stage head and neck squamous cell cancer survival. Clin. Cancer Res.18(1), 196–206 (2012).
  • Shi Q , WangX, CaiC, YangS, HuoN, LiuH. Association between TGF-β1 polymorphisms and head and neck cancer risk: a meta-analysis. Front. Genet.8, 169 (2017).
  • Ishikawa K , ImanishiH, TakenagaK, HayashiJ-I. Regulation of metastasis; mitochondrial DNA mutations have appeared on stage. J. Bioenerg. Biomembr.44(6), 639–644 (2012).
  • Ishikawa K , HayashiJ-I. Trading mtDNA uncovers its role in metastasis. Cell Adhes. Migr.3(1), 11–13 (2009).
  • Ishikawa K , TakenagaK, AkimotoMet al. ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science320(5876), 661–664 (2008).
  • Ishikawa K , KoshikawaN, TakenagaK, NakadaK, HayashiJ-I. Reversible regulation of metastasis by ROS-generating mtDNA mutations. Mitochondrion8(4), 339–344 (2008).
  • Fang H , ShenL, ChenTet al. Cancer type-specific modulation of mitochondrial haplogroups in breast, colorectal and thyroid cancer. BMC Cancer10(1), 421 (2010).
  • Takibuchi G , ImanishiH, MorimotoMet al. Polymorphic mutations in mouse mitochondrial DNA regulate a tumor phenotype. Mitochondrion13(6), 881–887 (2013).
  • Feeley KP , BrayAW, WestbrookDGet al. Mitochondrial genetics regulate breast cancer tumorigenicity and metastatic potential. Cancer Res.75(20), 4429–4436 (2015).
  • Yuan Y , WangW, LiHet al. Nonsense and missense mutation of mitochondrial ND6 gene promotes cell migration and invasion in human lung adenocarcinoma. BMC Cancer15(1), 346 (2015).
  • Li S , WanP, PengTet al. Associations between sequence variations in the mitochondrial DNA D-loop region and outcome of hepatocellular carcinoma. Oncol. Lett.11(6), 3723–3728 (2016).
  • Morris RW , KaplanNL. On the advantage of haplotype analysis in the presence of multiple disease susceptibility alleles. Genet. Epidemiol.23(3), 221–233 (2002).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.